Jagsonpal Pharmaceuticals Limited
Climate Impact & Sustainability Data (2020-03 to 2021-03, 2024-10, FY24)
Reporting Period: 2020-03 to 2021-03
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Not disclosed
Environmental Achievements
- Not disclosed
Social Achievements
- Not disclosed
Governance Achievements
- Not disclosed
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Not disclosed
Short-term Goals:
- Not disclosed
Environmental Challenges
- COVID-19 pandemic affected sales and operations.
Mitigation Strategies
- Sales were managed well despite the pandemic.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2024-10
Environmental Metrics
ESG Focus Areas
- Women's health
Social Achievements
- Established 7 pink toilets in schools and colleges of Punjab, Haryana and Uttarakhand under the ‘MySakhi’ initiative.
- Launched a dedicated website www.mysakhi.in focused on women’s health.
Governance Achievements
- Strengthened governance framework by appointing Walker Chandiok & Co LLP as statutory auditors, S S Kothari & Mehta as internal auditors, and Kirit Mehta & Co. as cost auditors.
- Board reconstituted with new members from Infinity Holdings and other independent directors.
Climate Goals & Targets
Long-term Goals:
- Improve EBITDA margins by 100-150 bps year-on-year for the next 3-4 years.
Medium-term Goals:
- Achieve 12% to 14% organic top-line growth.
Environmental Challenges
- Hypercompetition in dydrogesterone.
- Significant spurious product availability in Indomethacin franchise.
Mitigation Strategies
- Undertook decisive corrective measures to strengthen competitive position.
Supply Chain Management
Climate-Related Risks & Opportunities
Sustainable Products & Innovation
- MemUp
Reporting Period: FY24
Environmental Metrics
ESG Focus Areas
- Women's health and hygiene
Social Achievements
- Built sanitation facilities at multiple girl schools in Punjab and Uttarakhand.
- Launched mysakhi.in website to raise awareness and well-being of women.
Climate Goals & Targets
Short-term Goals:
- Concluding the acquisition of Yash Pharma’s business within 90-120 days.
Environmental Challenges
- Hypercompetition led inventory correction in Divatrone.
- Counterfeit Indocap SR in the marketplace.
Mitigation Strategies
- Inventory correction around Divatrone completed.
- Enhanced security features rolled out in all key brands to avoid counterfeit product availability.